ResMed Inc (RMD)
Current ratio
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 3,505,600 | 2,357,720 | 2,367,830 | 1,931,480 | 1,574,760 |
| Total current liabilities | US$ in thousands | 1,019,120 | 910,655 | 758,533 | 689,299 | 911,766 |
| Current ratio | 3.44 | 2.59 | 3.12 | 2.80 | 1.73 |
June 30, 2025 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,505,600K ÷ $1,019,120K
= 3.44
The analysis of ResMed Inc's current ratio over the specified periods indicates a pattern of increasing liquidity from June 30, 2021, to June 30, 2023. In 2021, the current ratio stood at 1.73, implying that the company's current assets were 1.73 times its current liabilities, reflecting adequate liquidity. This ratio increased significantly to 2.80 in 2022, and further to 3.12 in 2023, indicating an improving liquidity position and a stronger ability to meet short-term obligations.
Following this peak in 2023, the current ratio experienced a decline to 2.59 in 2024, which, while lower than the previous year, remains above the 2021 level, suggesting a slight reduction in liquidity but still maintaining a comfortable liquidity buffer. By June 30, 2025, the current ratio increased again to 3.44, reaching its highest point over the analyzed periods, which reflects a substantial strengthening of current assets relative to current liabilities.
Overall, the trend demonstrates that ResMed Inc has maintained a healthy and improving liquidity position across these fiscal years, with ratios consistently above 1.5, indicative of sufficient short-term financial stability. The fluctuations suggest periods of strategic asset management and/or changes in liabilities, with the recent increase pointing to a robust short-term liquidity profile as of mid-2025.
Peer comparison
Jun 30, 2025